Method, vaccine composition and kit for exciting specific mucosal immunoreaction
A technology of mucosal immunity and vaccine composition, which is applied in the field of vaccine combination and test kit to stimulate specific mucosal immune response, can solve the problems of difficult mucosal sIgA antibody and HIV mucosal vaccine research progress, etc. The effect of mucosal immunity
- Summary
- Abstract
- Description
- Claims
- Application Information
AI Technical Summary
Problems solved by technology
Method used
Image
Examples
Embodiment 1
[0048] Material:
[0049] VTKgpe (CGMCC No.1099): AIDS vaccine based on replicating vaccinia virus vector, expressing CN54gag-pol-env protein of HIV Chinese epidemic strain (HIV B / C subtype).
[0050] Recombinant gp140 trimer protein: derived from the CN54 membrane protein of HIV epidemic strain in China (see below).
[0051]Adjuvant: oil-in-water emulsion (ingredients: 0.5% (v / v) Tween 80, 0.5% (v / v) Span 85, 4.3% (v / v) squalene, water for injection, 10nM sodium citrate buffer liquid).
[0052] The immune strategy adopted in the present invention comprises the following steps:
[0053] Purchase 6-8 weeks old, SPF level BALB / c mice, and the primary immunogen is the AIDS vaccine VTKgpe (CGMCC No.1099), the immunization route is intramuscular injection, booster immunization 4 weeks after the initial immunization, the immunogen is the recombinant gp140 trimer constructed in this experiment (see below), the immunization route is intranasal immunization, and a booster immunizati...
PUM
Abstract
Description
Claims
Application Information
- R&D Engineer
- R&D Manager
- IP Professional
- Industry Leading Data Capabilities
- Powerful AI technology
- Patent DNA Extraction
Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic, Popular Technical Reports.
© 2024 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap|About US| Contact US: help@patsnap.com